Association of hypoadiponectinemia with non-alcoholic fatty liver disease in urban South Indians - (CURES - 81)

Indian Journal of Medical Research

Volumn 132, Issue 9, 2010, Pages 271-277

  Gokulakrishnan, K ^a   Anjana, R M ^a   Indulekha, K ^a   Anuradha, S ^a   Mohan, V ^a  

^a WHO Collaborating Centre for Non Communicable Diseases Prevention and Control   (India)

Author keywords

Adiponectin; Asian Indians; Diabetes; Fatty liver; Non alcoholic fatty liver disease; South Asians

Indexed keywords

ADIPONECTIN; CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HYPOADIPONECTINEMIA; INDIAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; PROTEIN DEFICIENCY; RADIOIMMUNOASSAY; WAIST CIRCUMFERENCE; ADULT; AGE; BLOOD; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FATTY LIVER; FEMALE; GLUCOSE TOLERANCE TEST; INDIA; MALE; MIDDLE AGED; PHYSIOLOGY; QUESTIONNAIRE; RISK; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICS; URBAN POPULATION;

ADIPONECTIN; ADULT; AGE FACTORS; BODY MASS INDEX; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FATTY LIVER; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INDIA; INSULIN RESISTANCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; QUESTIONNAIRES; RADIOIMMUNOASSAY; SEX FACTORS; TRIGLYCERIDES; URBAN POPULATION;

EID: 77957036187     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. American Gastroenterological Association. American 1. Gastroenterological Association medical position statement: Nonalcoholic fatty liver disease. Gastroenterology 2002; 123 1702-1704.
2. Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000; 132: 112-117.
3. Shibata M, Kihara Y, Taguchi M, Tashiro M, Otsuki M. Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men. Diabetes Care 2007; 30: 2940-2944,
4. Koh JH, Shin YG, Nam SM, Lee MY, Chung CH, Shin JY. Serum adipocyte fatty acid-binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients. Diabetes Care 2009; 32: 147-152.
5. Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract 2009; 84: 84-91.
6. Petersen KF, Dufour S, Feng J, Befroy D, Dziura J, Dalla Man C, et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci USA 2006; 103: 18273-18277.
7. Bajaj S, Nigam P, Luthra A, Pandey RM, Kondal D, Bhatt SP, et al. A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease. Indian J Med Res 2009; 129: 285-292.
8. Duseja A, Murlidharan R, Bhansali A, Sharma S, Das A, Das R, et al. Assessment of insulin resistance and effect of metformin in nonalcoholic steatohepatitis - a preliminary report. Indian J Gastroenterol 2004; 23: 12-15.
9. Kamada Y, Takehara T, Hayashi N. Adipocytokines and liver disease. J Gastroenterol 2008; 43: 811-822.
10. Sattar N, Nelson SM. Adiponectin, diabetes, and coronary heart disease in older persons: unraveling the paradox. J Clin Endocrinol Metab 2008; 93: 3299-3301.
11. Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, et al. Association of low adiponectin levels with the metabolic syndrome - the Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism 2005; 54: 476-481.
12. Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, et al. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 2004; 89: 200-206.
13. Yokoyama H, Hirose H, Ohgo H, Saito I. Inverse association between serum adiponectin level and transaminase activities in Japanese male workers. J Hepatol 2004; 41: 19-24.
14. Rajala MW, Scherer PE. Minireview: the adipocyte: at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003; 144: 3765-3773.
15. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-α or adiponectin? Hepatology 2004; 40: 46-54.
16. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 2003; 112: 91-100.
17. Deepa R, Sandeep S, Mohan V. Abdominal obesity, visceral fat and type 2 diabetes- ''Asian Indian Phenotype''. In: Mohan V, Gundu HR Rao, editors. Type 2 diabetes in south Asians: Epidemiology, risk factors and prevention. New Delhi: Jaypee Brothers Medical Publishers; 2006. p. 138-152.
18. Deepa M, Pradeepa R, Rema M, Mohan A, Deepa R, Shanthirani S, et al. The Chennai Urban Rural Epidemiology Study (CURES) - study design and methodology (urban component) (CURES-I). J Assoc Physicians India 2003; 51: 863-870.
19. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
20. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD, Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 1991; 43: 26-31.
21. Yoneda M, Iwasaki T, Fujita K, Kirikoshi H, Inamori M, Nozaki Y, et al. Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue. Alcohol Clin Exp Res 2007; 31 (Suppl 1): S15-S21.
22. Hulver MW, Saleh O, MacDonald KG, Pories WJ, Barakat HA. Ethnic differences in adiponectin levels. Metabolism 2004; 53: 1-3.
23. Abate N, Chandalia M, Snell PG, Grundy SM. Adipose tissue metabolites and insulin resistance in nondiabetic Asian Indian men. J Clin Endocrinol Metab 2004; 89: 2750-2755.
24. Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev 2002; 23: 201-229.
25. Unger RH. Minireview: Weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003; 144: 5159-5165.
26. Polyzos SA, Kountouras J, Zavos C, Tsiaousi E. The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. Diabetes Obes Metab 2010; 12: 365-383.
27. Chitturi S, Farrell G, Frost L, Kriketos A, Lin R, Fung C, et al. Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity? hepatology 2002; 36: 403-409.
28. Leclercq IA, Farrell GC, Schriemer R, Robertson GR. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol 2002; 37: 206-213.
29. Sahai A, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, et al. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 2004; 287: G1035-G1043.
30. Angulo P, Alba LM, Petrovic LM, Adams LA, Lindor KD, Jensen MD. Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease. J Hepatol 2004; 41: 943-949.
31. Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. hepatology 2003; 38: 413-419.
32. Day CP, James OF. Steatohepatitis: a tale of two ''hits''? Gastroenterology. 1998; 114: 842-845.
33. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-1419.
34. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004; 279: 12152-12162.
35. Wang Y, Lu G, Wong WP, Vliegenthart JF, Gerwig GJ, Lam KS, et al. Proteomic and functional characterization of endogenous adiponectin purified from fetal bovine serum. Proteomics 2004; 4: 3933-3942.